Biomarker commercialisation

Biomarkers are potential prognostic, diagnostic, and treatment indicators. Despite their increasing potential for precision medicine, their development into commercial products is very challenging. The purpose of a new Baltic Sea Region (BSR) consortium is to create tools for supporting and overcoming the challenges of biomarker commercialisation.

The objectives of the BIC consortium are to create

  • a biomarker development tool for researchers
  • a screening and selection guide for TTOs
  • a framework for technology translation into clinical setting
  • new business model templates
  • a biomarker platform with access to the tools and technology presentations for matchmaking

Funding source

The project's budget is EUR 2.55 million and is co-financed by the European Regional Development Fund through the Interreg Baltic Sea Region Programme with EUR 1.96 million.

    Official website


Best Practice Handbook

BIC Regulatory Guide

BIC Review Tool